Matrine impedes colorectal cancer proliferation and migration by downregulating endoplasmic reticulum lipid raft associated protein 1 expression

References

• Marmol I, Sanchez-de-diego C, Pradilla Dieste A, et al. Colorectal Carcinoma: a General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci. 2017;18(1):197.
   Web of Science ®Google Scholar
• Kanth P, Inadomi J. Screening and prevention of colorectal cancer. BMJ (Clin Res Ed). 2021;374:n1855.
   PubMedGoogle Scholar
• Gouverneur A, Coutureau J, Jove J, et al. Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: the STROMBOLI Cohort Study. Clin Colorectal Cancer. 2019;18(1):e150–e62.
   PubMed Web of Science ®Google Scholar
• Wrobel P, Ahmed S. Current status of immunotherapy in metastatic colorectal cancer. Int J Colorectal Dis. 2019;34(1):13–25.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.03.009
   PubMed Web of Science ®Google Scholar
• Chen L, Jiang X, Zhang Q, et al. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC. Clin Immunol. 2022;237:108962.
   PubMed Web of Science ®Google Scholar
• Huang J, Xu H. Matrine: bioactivities and Structural Modifications. Curr Top Med Chem. 2016;16(28):3365–3378.
   PubMed Web of Science ®Google Scholar
• Li Q, Xu J, He Z, et al. The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer. Cancer Manag Res. 2019;11:10125–10133.
   PubMed Web of Science ®Google Scholar
• Khan A, Shal B, Naveed M, et al. Matrine alleviates neurobehavioral alterations via modulation of JNK-mediated caspase-3 and BDNF/VEGF signaling in a mouse model of burn injury. Psychopharmacology (Berl). 2020;237(8):2327–2343.
   PubMed Web of Science ®Google Scholar
• Zhao L, Cai H, Tang Z, et al. Matrine suppresses advanced glycation end products-induced human coronary smooth muscle cells phenotype conversion by regulating endoplasmic reticulum stress-dependent Notch signaling. Eur J Pharmacol. 2020;882:173257.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen L, Sun X, et al. Matrine: a Promising Natural Product With Various Pharmacological Activities. Front Pharmacol. 2020;11:588.
   PubMed Web of Science ®Google Scholar
• Chen A, Fang D, Ren Y, et al. Matrine protects colon mucosal epithelial cells against inflammation and apoptosis via the Janus kinase 2 /signal transducer and activator of transcription 3 pathway. Bioengineered. 2022;13(3):6490–6499.
   PubMed Web of Science ®Google Scholar
• Fu S, Zhao N, Jing G, et al. Matrine induces papillary thyroid cancer cell apoptosis in vitro and suppresses tumor growth in vivo by downregulating miR-182-5p. Biomed Pharmacother. 2020;128:110327.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Yu C, Li W, et al. Matrine Inhibits Proliferation, Invasion, and Migration and Induces Apoptosis of Colorectal Cancer Cells Via miR-10b/PTEN Pathway. Cancer Biother Radiopharm. 2020. DOI:10.1089/cbr.2020.3800
   Web of Science ®Google Scholar
• Du J, Li J, Song D, et al. Matrine exerts antibreast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF7 cells. Mol Med Rep. 2020;22:3659–3666.
   PubMed Web of Science ®Google Scholar
• Ren H, Zhang S, Ma H, et al. Matrine reduces the proliferation and invasion of colorectal cancer cells via reducing the activity of p38 signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2014;46(12):1049–1055.
   PubMed Web of Science ®Google Scholar
• Liu J, Guo Y, Cao J. Matrine triggers colon cancer cell apoptosis and G0/G1 cell cycle arrest via mediation of microRNA-22. Phytother Res. 2020;34(7):1619–1628.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang W, Ren L, et al. Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression. J Transl Med. 2022;20(1):106.
   PubMed Web of Science ®Google Scholar
• Bai L, Yan X, Lu Y, et al. Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: a Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection. Ann Surg Oncol. 2022. DOI:10.1245/s10434-021-11234-0.
   Web of Science ®Google Scholar
• Bosch S, Acharjee A, Quraishi M, et al. The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma. Gut Microbes. 2022;14(1):2038863.
   PubMed Web of Science ®Google Scholar
• Grady WM, Yu M, Markowitz SD. Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer. Gastroenterology. 2020;160(3):690–709.
   PubMed Web of Science ®Google Scholar
• Wang X, Li T. Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer. Bioengineered. 2020;11(1):165–174.
   PubMed Web of Science ®Google Scholar
• Ilango S, Paital B, Jayachandran P, et al. Epigenetic alterations in cancer. Front Biosci (Landmark Ed). 2020;25(6):1058–1109.
   PubMedGoogle Scholar
• Browman DT, Hoegg MB, Robbins SM. The SPFH domain-containing proteins: more than lipid raft markers. Trends Cell Biol. 2007;17(8):394–402.
   PubMed Web of Science ®Google Scholar
• Tian WT, Shen JY, Liu XL, et al. Novel Mutations in Endoplasmic Reticulum Lipid Raft-associated Protein 2 Gene Cause Pure Hereditary Spastic Paraplegia Type 18. Chin Med J (Engl). 2016;129(22):2759–2761.
   PubMed Web of Science ®Google Scholar
• Tunca C, Akcimen F, Coskun C, et al. ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. Eur J Hum Genet. 2018;26(5):745–748.
   PubMed Web of Science ®Google Scholar
• Xi T, Zhang G, Ahmad A. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma. PLoS One. 2018;13(3):e0193427.
   PubMed Web of Science ®Google Scholar
• Dabaghi M, Hilger I. Magnetic Nanoparticles Behavior in Biological Solutions; The Impact of Clustering Tendency on Sedimentation Velocity and Cell Uptake. In: Materials(Basel);Switzerland; 2020;13(7):1644.
   Google Scholar
• Laali KK, Greves WJ, Zwarycz AT, et al. Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity. ChemMedChem. 2018;13(18):1895–1908.
   PubMed Web of Science ®Google Scholar
• Yue T, Chen S, Zhu J, et al. The aging-related risk signature in colorectal cancer. Aging (Albany NY). 2021;13(5):7330–7349.
   PubMedGoogle Scholar
• Tang J, Chen JX, Chen L, et al. Metastasis associated in colon cancer 1 (MACC1) promotes growth and metastasis processes of colon cancer cells. Eur Rev Med Pharmacol Sci. 2016;20(13):2825–2834.
   PubMed Web of Science ®Google Scholar
• Fan H, Jiang C, Zhong B, et al. Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1. J Immunol Res. 2018;2018:5408324.
   PubMed Web of Science ®Google Scholar
• Vinci M, Gowan S, Boxall F, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10(1):29.
   PubMed Web of Science ®Google Scholar
• Wu G, Xu X, Wan D, et al. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer. Ann Transl Med. 2021;9(16):1317.
   PubMed Web of Science ®Google Scholar
• Liu L, Xie D, Xie H, et al. ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway. Onco Targets Ther. 2019;12:11507–11516.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhao J, Liang Y, et al. MicroRNA-10b controls the metastasis and proliferation of colorectal cancer cells by regulating Krüppel-like factor 4. Artif Cells Nanomed Biotechnol. 2019;47(1):1722–1729.
   PubMed Web of Science ®Google Scholar
• Luan Y, Li X, Luan Y, et al. Circulating lncRNA UCA1 Promotes Malignancy of Colorectal Cancer via the miR-143/MYO6 Axis. Mol Ther Nucleic Acids. 2020;19:790–803.
   PubMedGoogle Scholar
• Disoma C, Zhou Y, Li S, et al. Wnt/β-catenin signaling in colorectal cancer: is therapeutic targeting even possible? Biochimie. 2022;195:39–53.
   PubMed Web of Science ®Google Scholar
• Oliveira L, Predes D, Borges H, et al. Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer. Cancers (Basel). 2022;14(2):403.
   PubMed Web of Science ®Google Scholar
• Luo C, Zhong HJ, Zhu LM, et al. Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism. Mol Biol Rep. 2012;39(5):5459–5464.
   PubMed Web of Science ®Google Scholar
• Zhang GL, Jiang L, Yan Q, et al. Anti-tumor effect of matrine combined with cisplatin on rat models of cervical cancer. Asian Pac J Trop Med. 2015;8(12):1055–1059.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu Y, Ji W, et al. Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol. 2014;35(6):5111–5119.
   PubMed Web of Science ®Google Scholar
• Ma LD, Zhang Y, Wen SH, et al. Enhancing effect of matrine on the tumor-inhibition by TIM2 gene-modified hepatocarcinoma H22 cells in mice. Zhonghua Zhong Liu Za Zhi. 2008;30(4):255–258.
   PubMedGoogle Scholar
• Wang JK, Zhao BS, Wang M, et al. Anti-tumor and Phenotypic Regulation Effect of Matrine on Dendritic Cells through Regulating TLRs Pathway. Chin J Integr Med. 2020;27(7):520–526.
   PubMed Web of Science ®Google Scholar
• Feitosa MF, Wojczynski MK, North KE, et al. The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study. Atherosclerosis. 2013;228(1):175–180.
   PubMed Web of Science ®Google Scholar
• Inoue T, Tsai B, Atwood WJ. Regulated Erlin-dependent release of the B12 transmembrane J-protein promotes ER membrane penetration of a non-enveloped virus. PLoS Pathog. 2017;13(6):e1006439.
   PubMed Web of Science ®Google Scholar
• Manganelli V, Longo A, Mattei V, et al. Role of ERLINs in the Control of Cell Fate through Lipid Rafts. Cells. 2021;10(9):2408.
   PubMed Web of Science ®Google Scholar
• Manganelli V, Matarrese P, Antonioli M, et al. Raft-like lipid microdomains drive autophagy initiation via AMBRA1-ERLIN1 molecular association within MAMs. Autophagy. 2021;17(9):2528–2548.
   PubMed Web of Science ®Google Scholar
• Whitten-Bauer C, Chung J, Gómez-Moreno A, et al. The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus Infection. Cells. 2019;8(12):1555.
   Web of Science ®Google Scholar
• Looi QH, Foo JB, Lim MT, et al. How far have we reached in development of effective influenza vaccine? Int Rev Immunol. 2018;37(5):266–276.
   PubMed Web of Science ®Google Scholar